scispace - formally typeset
H

Hani Z. Asfour

Researcher at King Abdulaziz University

Publications -  71
Citations -  1194

Hani Z. Asfour is an academic researcher from King Abdulaziz University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 15, co-authored 62 publications receiving 608 citations.

Papers
More filters
Journal ArticleDOI

Anti-Quorum Sensing Natural Compounds.

TL;DR: A brief account of the research reports on the plants and natural compounds with anti-QS potential is given, which have recently received considerable attention as a new source of safe and effective QS inhibitory substances.
Journal ArticleDOI

In silico analysis of Single Nucleotide Polymorphisms (SNPs) in human BRAF gene

TL;DR: In silico analysis suggested that S136A and P764L variants of BRAF could directly or indirectly destabilize the amino acid interactions and hydrogen bond networks thus explain the functional deviations of protein to some extent.
Journal ArticleDOI

Fusaripeptide A: new antifungal and anti-malarial cyclodepsipeptide from the endophytic fungus Fusarium sp.

TL;DR: A new cyclodepsipeptide, namely fusaripeptide A, along with three known compounds adenosine (2), 2[(2-hydroxypropionyl)amino]benzamide (3), and cyclopentanol (4), have been isolated, using extensive 1D and 2D NMR and HRESI and GC mass spectral data.
Journal ArticleDOI

Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells.

TL;DR: Stable naringenin nanoemulsions were more effective than the NAR solution in reducing Bcl2 expression, while increasing pro-apoptotic Bax and caspase-3 activity and could be a suitable drug delivery system to enhance the effects of NAR in the treatment of lung cancer.
Journal ArticleDOI

Decellularised extracellular matrix-derived peptides from neural retina and retinal pigment epithelium enhance the expression of synaptic markers and light responsiveness of human pluripotent stem cell derived retinal organoids

TL;DR: Enhanced rod photoreceptor differentiation, synaptogenesis and light response in response to addition of decellularised matrices from RPE and neural retina as shown herein provide a novel and substantial advance in generation of retinal organoids for drug screening, tissue engineering and regenerative medicine.